April 23, 2021
Business News

Why mRNA vaccines like those being made to treat coronavirus are a quantum leap for biotech – Salon

If the Pfizer and Moderna vaccines successfully put an end to the COVID-19 pandemic, as they seem poised to do, we will owe our salvation to the development of mRNA vaccines — an unprecedented, novel vaccine technology that may revolutionize how vaccines are made.
Indeed, an mRNA vaccine has never been mass-produced and licensed to treat an infectious disease. The mRNA vaccines to treat the novel coronavirus would be the first.
Yet understanding the quantum leap that mRNA vaccines represent requires…

Click here to view the original article.

Related Posts

You might also like ...

Netsmart and Vermont Collaborative Launch Care Coordination Platform to Deliver on Data-Driven, Value-Based Care
Shorla Pharma Announces FDA Filing Acceptance and Priority Review for T-cell Leukemia Treatment
Anthony Goodman Joins Korn Ferry as Senior Client Partner and Head of Board Effectiveness Practice